Sono-Tek Receives Hold Rating from Northland Securities' Ted Jackson
PorAinvest
miércoles, 25 de junio de 2025, 5:21 am ET1 min de lectura
SOTK--
Sono-Tek Corporation (SOTK) has received a significant $1.12 million order from a long-standing client in the medical diagnostic testing industry. This substantial order represents a major evolution in the company's relationship with the client, which has been utilizing Sono-Tek's ultrasonic coating systems for nearly a decade. The order includes a system designed for advanced automation and high-volume product handling, reflecting Sono-Tek's enhanced capabilities [1].
The new system is engineered to support sophisticated automation and reduced operator intervention, enabling scalable production of advanced diagnostic consumables. Delivery and installation are scheduled at the customer’s U.S. facility within the next year. This order aligns with Sono-Tek’s ongoing strategy to deliver fully integrated, high-performance coating platforms that support the scalability and automation demands of high-volume manufacturing in innovation-driven industries such as medical devices, alternative energy, and microelectronics [1].
Sono-Tek, founded in 1975, has evolved from delivering precision coating solutions to R&D and laboratory markets to becoming a global leader in providing scalable, high-performance manufacturing platforms. Today, Sono-Tek’s systems enable thin-film deposition with exceptional uniformity, material efficiency, and process control for advanced applications in medical devices, micro-electronics, alternative energy, and industrial production [1].
The order comes at a time when Sono-Tek reported stable financial performance in its second quarter. The company achieved an earnings per share of $0.02 and revenue of $5.12 million, showcasing stable performance despite market challenges [3]. The company maintains a strong cash position with $11.9 million in cash and equivalents and no debt, supporting its growth initiatives [3].
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek, citing the company's recent order as a positive development. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. The analyst consensus remains Hold [2].
References:
[1] https://www.globenewswire.com/news-release/2025/06/23/3103240/0/en/Sono-Tek-Receives-1-12-Million-Order-from-Global-Medical-Diagnostics-Company-for-High-Volume-Coating-Platform.html
[2] https://www.gurufocus.com/news/2940046/sonotek-sotk-secures-significant-112m-order-in-medical-diagnostics-sotk-stock-news
[3] https://www.investing.com/news/company-news/sonotek-receives-112-million-order-from-medical-diagnostics-client-93CH-4105507
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek (SOTK). The company reported a quarterly revenue of $5.19 million and a net profit of $274.18 thousand. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. Sono-Tek has an analyst consensus of Hold.
Title: Sono-Tek Secures $1.12 Million Order from Global Medical Diagnostics CompanySono-Tek Corporation (SOTK) has received a significant $1.12 million order from a long-standing client in the medical diagnostic testing industry. This substantial order represents a major evolution in the company's relationship with the client, which has been utilizing Sono-Tek's ultrasonic coating systems for nearly a decade. The order includes a system designed for advanced automation and high-volume product handling, reflecting Sono-Tek's enhanced capabilities [1].
The new system is engineered to support sophisticated automation and reduced operator intervention, enabling scalable production of advanced diagnostic consumables. Delivery and installation are scheduled at the customer’s U.S. facility within the next year. This order aligns with Sono-Tek’s ongoing strategy to deliver fully integrated, high-performance coating platforms that support the scalability and automation demands of high-volume manufacturing in innovation-driven industries such as medical devices, alternative energy, and microelectronics [1].
Sono-Tek, founded in 1975, has evolved from delivering precision coating solutions to R&D and laboratory markets to becoming a global leader in providing scalable, high-performance manufacturing platforms. Today, Sono-Tek’s systems enable thin-film deposition with exceptional uniformity, material efficiency, and process control for advanced applications in medical devices, micro-electronics, alternative energy, and industrial production [1].
The order comes at a time when Sono-Tek reported stable financial performance in its second quarter. The company achieved an earnings per share of $0.02 and revenue of $5.12 million, showcasing stable performance despite market challenges [3]. The company maintains a strong cash position with $11.9 million in cash and equivalents and no debt, supporting its growth initiatives [3].
Northland Securities analyst Ted Jackson maintained a Hold rating on Sono-Tek, citing the company's recent order as a positive development. Jackson has a 4-star rating with an average return of 7.2% and a 51.55% success rate. The analyst consensus remains Hold [2].
References:
[1] https://www.globenewswire.com/news-release/2025/06/23/3103240/0/en/Sono-Tek-Receives-1-12-Million-Order-from-Global-Medical-Diagnostics-Company-for-High-Volume-Coating-Platform.html
[2] https://www.gurufocus.com/news/2940046/sonotek-sotk-secures-significant-112m-order-in-medical-diagnostics-sotk-stock-news
[3] https://www.investing.com/news/company-news/sonotek-receives-112-million-order-from-medical-diagnostics-client-93CH-4105507

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios